Yamamoto K, Ishii E, Sako M, Ohga S, Furuno K, Suzuki N, Ueda I, Imayoshi M, Yamamoto S, Morimoto A, Takada H, Hara T, Imashuku S, Sasazuki T, Yasukawa M
Division of Molecular Population Genetics, Department of Molecular Genetics, Medical Institute of Bioregulation, and Kyushu University COE Programme on Lifestyle-Related Diseases, Kyushu University, Japan.
J Med Genet. 2004 Oct;41(10):763-7. doi: 10.1136/jmg.2004.021121.
Familial haemophagocytic lymphohistiocytosis (FHL) has an autosomal recessive mode of inheritance and consists of at least three subtypes. FHL2 subtype with perforin (PRF1) mutation accounts for 30% of all FHL cases, while FHL with MUNC13-4 mutation was recently identified and designated as FHL3 subtype.
To examine MUNC13-4 mutations and the cytotoxic function of MUNC13-4 deficient T lymphocytes in Japanese FHL patients
Mutations of MUNC13-4 and the cytotoxicity of MUNC13-4-deficient cytotoxic T lymphocytes (CTL) were analysed in 16 Japanese families with non-FHL2 subtype.
Five new mutations of the MUNC13-4 gene were identified in six families. The mutations were in the introns 4, 9, and 18, and exons 8 and 19. Two families had homozygous mutations, while the remaining four had compound heterozygous mutations. Cytotoxicity of MUNC13-4 deficient CTL was low compared with control CTL, but was still present. Clinically, the onset of disease tended to occur late; moreover, natural killer cell activity was not deficient in some FHL3 patients.
MUNC13-4 mutations play a role in the development of FHL3 through a defective cytotoxic pathway.
家族性噬血细胞性淋巴组织细胞增生症(FHL)呈常染色体隐性遗传模式,至少包括三个亚型。伴有穿孔素(PRF1)突变的FHL2亚型占所有FHL病例的30%,而最近发现伴有MUNC13 - 4突变的FHL并将其指定为FHL3亚型。
检测日本FHL患者中MUNC13 - 4突变情况以及MUNC13 - 4缺陷型T淋巴细胞的细胞毒性功能。
对16个非FHL2亚型的日本家族分析MUNC13 - 4突变情况以及MUNC13 - 4缺陷型细胞毒性T淋巴细胞(CTL)的细胞毒性。
在6个家族中鉴定出5个新的MUNC13 - 4基因突变。这些突变位于第4、9和18内含子以及第8和19外显子。2个家族为纯合突变,其余4个为复合杂合突变。与对照CTL相比,MUNC13 - 4缺陷型CTL的细胞毒性较低,但仍存在。临床上,疾病发病往往较晚;此外,一些FHL3患者的自然杀伤细胞活性并不缺乏。
MUNC13 - 4突变通过缺陷的细胞毒性途径在FHL3的发生中起作用。